Salt CompositionPramipexole 1.25mg
You Searched
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Parkinson's disease / Restless leg syndrome
Customers also bought
More About Pramipex 1.25mg Tablet ER
Benefits
In Parkinson's disease Pramipex 1.25mg Tablet ER is effective in relieving symptoms of Parkinson's disease such as tremors, muscle stiffness, and difficulty moving. It increases the amount of a chemical called dopamine in the brain which helps in the coordination of body movements. This medicine can therefore enhance the quality of life by improving the ability to carry out daily functions in a better manner. In Restless leg syndrome Restless leg syndrome is a condition that causes an uncontrollable urge to move your legs, usually because of an uncomfortable sensation. It typically happens in the evening or nighttime hours when you're sitting or lying down. Moving or walking, that is change in posture, will control the unpleasant feeling temporarily. Pramipex 1.25mg Tablet ER helps to relieve this uncomfortable urge and calms these sensations. Take it as advised by the doctor to get the maximum relief.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Pramipex 1.25mg Tablet ER is to be taken with food.
How it works
Pramipex 1.25mg Tablet ER works by increasing the action of dopamine, a chemical messenger that is needed to control movement in the brain.
Unsafe: Avoid consuming alcohol with Pramipex 1.25mg Tablet ER as it is deemed unsafe.
Seek medical advice from your doctor: Pramipex 1.25mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Pramipex 1.25mg Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Pramipex 1.25mg Tablet ER suppresses serum prolactin and may interfere with breastfeeding.
Not Safe: Pramipex 1.25mg Tablet ER may cause side effects which could affect your ability to drive. Pramipex 1.25mg Tablet ER can cause hallucinations (seeing, hearing or feeling things that are not there). This may affect your ability to drive.
Caution Advised: Pramipex 1.25mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Pramipex 1.25mg Tablet ER may be needed. Doctor consultation is advised.
Safe when prescribed by an expert: Pramipex 1.25mg Tablet ER is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Pramipex 1.25mg Tablet ER may not be needed in these patients. Doctor consultation is advised.
Manufacturer Address
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
References
Aminoff MJ. Pharmacologic Management of Parkinsonism & Other Movement Disorders. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 475-76
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1140-41
Pramipexole dihydrochloride. Ridgefield, Connecticut: Boehringer Ingelheim International GmbH; 2010 (22 Jan. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (22 Mar. 2019)
Pramipexole. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2012 (22 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (07 Aug. 2023)
Pramipexole dihydrochloride (05 Aug. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
